We are live on ! Find out more
VIM

Veritas Investment Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+25.54%
3 Year Est. Return
+69.01%
5 Year Est. Return
+144.34%
10 Year Est. Return
AUM
$723M
AUM Growth
-$17.2M
Cap. Flow
-$57.3M
Cap. Flow %
-7.93%
Top 10 Hldgs %
90.33%
Holding
65
New
Increased
5
Reduced
14
Closed
2

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$3.52M
2
CTSH icon
Cognizant
CTSH
+$3.01M
3
CMCSA icon
Comcast
CMCSA
+$2.24M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$406K
5
CVS icon
CVS Health
CVS
+$307K

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$38.3M
2
UNH icon
UnitedHealth
UNH
+$9.68M
3
MSFT icon
Microsoft
MSFT
+$7.25M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.1M
5
MA icon
Mastercard
MA
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 37.26%
2 Communication Services 21.98%
3 Technology 20.54%
4 Financials 18.77%
5 Consumer Staples 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$389B
$90.7M 12.55%
410,833
-45,693
-10% -$9.68M
MSFT icon
2
Microsoft
MSFT
$2.92T
$85.8M 11.88%
1,002,947
-88,431
-8% -$7.25M
CMCSA icon
3
Comcast
CMCSA
$85.8B
$77.9M 10.77%
1,942,769
+59,685
+3% +$2.24M
TMO icon
4
Thermo Fisher Scientific
TMO
$214B
$74.7M 10.34%
393,362
-26,641
-6% -$5.1M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.11T
$64.7M 8.95%
325,543
-1,580
-0.5% -$300K
MA icon
6
Mastercard
MA
$497B
$59.1M 8.17%
389,030
-24,037
-6% -$3.57M
CTSH icon
7
Cognizant
CTSH
$23.8B
$56.3M 7.79%
792,127
+41,175
+5% +$3.01M
CVS icon
8
CVS Health
CVS
$140B
$52.2M 7.22%
718,928
+4,220
+0.6% +$307K
LH icon
9
Labcorp
LH
$25.8B
$49.1M 6.79%
358,036
+26,648
+8% +$3.52M
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.07T
$42.3M 5.85%
808,460
+7,980
+1% +$406K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.08T
$38.1M 5.27%
723,220
-11,060
-2% -$571K
NTRS icon
12
Northern Trust
NTRS
$22.2B
$4.6M 0.64%
46,056
-6,444
-12% -$614K
MO icon
13
Altria Group
MO
$125B
$4.57M 0.63%
63,980
MCO icon
14
Moody's
MCO
$83.9B
$2.99M 0.41%
20,260
-1,840
-8% -$270K
ORCL icon
15
Oracle
ORCL
$346B
$2.03M 0.28%
42,917
-781,578
-95% -$38.3M
MRSH
16
Marsh
MRSH
$91.7B
$1.63M 0.23%
20,042
-8,158
-29% -$678K
ALGN icon
17
Align Technology
ALGN
$12.6B
$1.62M 0.22%
7,308
-230
-3% -$52.2K
FISV
18
Fiserv Inc
FISV
$28.9B
$1.47M 0.2%
22,400
PAYX icon
19
Paychex
PAYX
$42.3B
$1.26M 0.17%
18,463
AAPL icon
20
Apple
AAPL
$4.99T
$1.01M 0.14%
23,888
BNY
21
Bank of New York Mellon
BNY
$106B
$883K 0.12%
16,387
RTX icon
22
RTX Corp
RTX
$295B
$621K 0.09%
7,730
UNP icon
23
Union Pacific
UNP
$175B
$571K 0.08%
4,250
KEY icon
24
KeyCorp
KEY
$24.3B
$542K 0.08%
26,844
XYL icon
25
Xylem
XYL
$29.7B
$524K 0.07%
7,680

Similar funds

Veritas Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Veritas Investment Management held 65 positions worth $723M, down 2.3% from $740M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Veritas Investment Management withdrew a net $57.3M in Q4 2017, closing 2 positions and reducing 14 holdings. Its most notable exit was Quest Diagnostics, an estimated $122K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 37% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Veritas Investment Management added an estimated $3.52M to Labcorp.

  • Veritas Investment Management added most to Labcorp in Q4 2017, an estimated $3.52M increase.
  • Veritas Investment Management's biggest Q4 2017 reduction was Oracle, cutting an estimated $38.3M.
  • Veritas Investment Management fully exited Quest Diagnostics in Q4 2017, selling an estimated $122K.
  • Veritas Investment Management's ten largest holdings make up 90% of its $723M portfolio in Q4 2017.
  • Veritas Investment Management opened 0 new positions and closed 2 in Q4 2017.
  • Veritas Investment Management's portfolio value fell 2.3% quarter-over-quarter to $723M.

Based on Veritas Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.